Through the development of proteins that block the death receptor apoptotic pathway, inhibitors of apoptosis (IAPs), anti-apoptotic Bcl-2 family members and other anti-apoptotic proteins, NF-κB activation in cancer can result in apoptosis resistance [108]. The gene discussed is NFKB1; the disease is cancer.